Hank Mansbach
2020
In 2020, Hank Mansbach earned a total compensation of $1.7M as Chief Medical Officer at 89bio, a 124% increase compared to previous year.
Compensation breakdown
| Bonus | $49,106 |
|---|---|
| Non-Equity Incentive Plan | $177,778 |
| Option Awards | $1,063,229 |
| Salary | $420,000 |
| Other | $3,118 |
| Total | $1,713,231 |
Mansbach received $1.1M in option awards, accounting for 62% of the total pay in 2020.
Mansbach also received $49.1K in bonus, $177.8K in non-equity incentive plan, $420K in salary and $3.1K in other compensation.
Rankings
In 2020, Hank Mansbach's compensation ranked 6,246th out of 13,090 executives tracked by ExecPay. In other words, Mansbach earned more than 52.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,246 out of 13,090 | 52nd |
Division Manufacturing | 2,573 out of 5,624 | 54th |
Major group Chemicals And Allied Products | 1,036 out of 2,257 | 54th |
Industry group Drugs | 895 out of 1,957 | 54th |
Industry Pharmaceutical Preparations | 668 out of 1,462 | 54th |
Source: SEC filing on April 15, 2021.
Mansbach's colleagues
We found two more compensation records of executives who worked with Hank Mansbach at 89bio in 2020.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020